GID gi dynamics, inc
Add to My Watchlist 0.00% ! 0.2¢

News: GI Dynamics to reveal trial results

  1. Proactive
    clock Created with Sketch.
    29/07/15
    15:42
    Post #: 15714861

    GI Dynamics (ASX:GID) has been granted a trading halt by the ASX this afternoon pending the company's ENDO Trial.

    GID is the developer of EndoBarrier®, the first endoscopically-delivered device therapy approved for the treatment of obese type 2 diabetes.

    The halt will remain in place until the opening of trade on Friday 31st July 2015, or earlier if an announcement is made to the market.

     

    Likes Created with Sketch.  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS Lithium hype is back. Just ignore the fact Jianxiawo only supplies 3% globally
right-arrow Created with Sketch.
NEWS DroneShield's civilian counter-drone tech lands with a buzz
right-arrow Created with Sketch.
NEWS The 10 hot stocks HotCopper users watchlisted in Week 32
right-arrow Created with Sketch.
NEWS What the hell is wrong with ASX Ltd? The hits keep coming, and now CBOE looms
right-arrow Created with Sketch.
NEWS Iress Ltd leads top gainers intraday Friday as Blackstone buyout bid confirmed
right-arrow Created with Sketch.
NEWS Win a $12k Portfolio | 7%-10.25% low risk rental yield from a proven asset
right-arrow Created with Sketch.
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.